Загрузка...
Key differences between apoC-III regulation and expression in intestine and liver
ApoC-III is a critical cardiovascular risk factor, and humans expressing null mutations in apoC-III are robustly protected from cardiovascular disease. Because of its critical role in elevating plasma lipids and CVD risk, hepatic apoC-III regulation has been studied at length. Considerably less is k...
Сохранить в:
| Опубликовано в: : | Biochem Biophys Res Commun |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069593/ https://ncbi.nlm.nih.gov/pubmed/28739253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2017.07.116 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|